pSivida Corp

Press Releases

All Releases
View Summary pSivida Submits Marketing Authorization Application (MAA) for Approval of Durasert™ Three-year Treatment for Posterior Segment Uveitis in the European Union
Jun 22, 2017
PDF 21.0 KB Add to Briefcase
View Summary pSivida's Durasert™ Three-year Treatment for Posterior Segment Uveitis Successfully Achieves Primary Efficacy Endpoint in Second Phase 3 Study
Jun 13, 2017
PDF 22.5 KB Add to Briefcase
View Summary Durasert™ Three-year Treatment for Posterior Segment Uveitis Significantly Reduces Recurrences Through 12 Months
May 8, 2017
PDF 21.0 KB Add to Briefcase
View Summary pSivida Corp. Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track
May 4, 2017
PDF 38.7 KB Add to Briefcase
View Summary pSivida Corp. to Report Third Quarter Fiscal Year 2017 Financial Results on Thursday, May 4th
Apr 19, 2017
PDF 18.2 KB Add to Briefcase
View Summary Abstract on pSivida's Treatment of Posterior Segment Uveitis Accepted for Presentation at the 2017 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Mar 15, 2017
PDF 19.0 KB Add to Briefcase
View Summary pSivida to Present at the 2017 BIO CEO & Investor Conference
Feb 10, 2017
PDF 15.5 KB Add to Briefcase
View Summary pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results
Feb 7, 2017
PDF 35.0 KB Add to Briefcase
View Summary pSivida Corp. Announces Second Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information
Jan 25, 2017
PDF 18.4 KB Add to Briefcase
View Summary Seasoned Ophthalmology Executive Deb Jorn Joins pSivida to Focus on Corporate and Commercial Development
Nov 7, 2016
PDF 16.4 KB Add to Briefcase
View Summary pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives & Milestone Timeline
Nov 7, 2016
PDF 32.7 KB Add to Briefcase
View Summary pSivida Corp. Announces First Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information
Oct 31, 2016
PDF 17.9 KB Add to Briefcase
View Summary Phase 3 trial of Medidur™ in Posterior Segment Uveitis Meets Enrollment Target
Oct 4, 2016
PDF 19.1 KB Add to Briefcase
View Summary pSivida Corp. Strengthens Board of Directors With Leading Ophthalmologist
Sep 27, 2016
PDF 18.2 KB Add to Briefcase
View Summary pSivida to Present at the Ladenburg Thalmann Annual Healthcare Conference
Sep 22, 2016
PDF 14.0 KB Add to Briefcase
View Summary pSivida Reports Inducement Awards to New President and Chief Executive Officer
Sep 20, 2016
PDF 14.0 KB Add to Briefcase
View Summary pSivida Implements Leadership Change -- Nancy Lurker Named as President and CEO
Sep 15, 2016
PDF 18.7 KB Add to Briefcase
View Summary pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2016 Results
Sep 12, 2016
PDF 37.8 KB Add to Briefcase
View Summary pSivida Corp. Announces Fourth Quarter and Fiscal Year 2016 Financial Results Release Date and Conference Call Information
Sep 1, 2016
PDF 14.1 KB Add to Briefcase
View Summary pSivida Announces 13 New Patents Issued or Allowed
Aug 29, 2016
PDF 17.4 KB Add to Briefcase
Showing 1-20 of 275 Page: 1 2 3 4 5 ... 14  Next 20
Add to Briefcase = add release to Briefcase

Search Investor Relations

pSivida